3Vargas HO, Kox WJ, Spies C, el al.Anticoagulation in continuous renal replacement therapy. Contrib Nephrol Basel Karger,2004:308-316.
4Powe NR, Jaar B, Furth SL, et al. Septicemia in dialysis patients: incidence, risk factors, and prognosis[J]. Kidney Int, 1999,55: 1081-1090.
5Marr K, Krekland, Seefon D, et al. Catheter related bacteremia in hemodialysis patients[J]. Ann Intern Med, 1997.
6Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population[J]. Kidney Int, 2000,58: 1758-1764.
7Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention [J]. MMWR Recomm Rep, 2002, 51:1-29.
8Shortell SM, Bennett CL, Byck GR. Assessing the impact of continuous quality improvement on clinical practice: what it will take to accelerate progress[J]. Milbank Q, 1998, 76:593-624, 510.
9Mermel LA, Farr BM. Guidelines for the Prevention of Intravascular Catheter -Related Infections[J].Clinical Infectious Disease, 2001,22:222-242.
10Burr R, Marszalek J, Saul M. The cost of vascular access infections: three years experience from a single outpatient dialysis center[J]. Hemodial Int, 2003,7:73-104.
